How the AAD Clinical Image Collection Can Help Dermatologists, With Vinod Nambudiri, MD, MBA, MPH

At the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, an on-site segment of the Skin of Color Savvy podcast brought forward a timely and clinically relevant discussion with Vinod Nambudiri, MD, MBA, MPH, of Brigham and Women’s Hospital, centered on advancing dermatologic care for diverse patient populations. The conversation highlighted both the progress made and the ongoing gaps in addressing conditions that disproportionately affect individuals with skin of color, with a particular emphasis on health equity, access to care, and emerging therapeutic strategies.

A central theme of Nambudiri’s discussion was the importance of recognizing how dermatologic diseases can present differently across skin tones, and how these variations can contribute to delayed diagnosis or misdiagnosis. The speakers emphasized that improving clinician education remains critical, particularly in ensuring that providers are trained to identify subtle or atypical presentations in darker skin types. This gap in training continues to be a barrier to optimal care and underscores the need for more inclusive educational resources and clinical imagery.

The conversation also explored the psychosocial burden of dermatologic conditions in patients with skin of color, noting that visible skin diseases often carry significant stigma. This burden can be further compounded by cultural perceptions, societal pressures, and disparities in access to specialized care. As such, Nambudiri stressed the importance of culturally competent care and shared decision-making, ensuring that treatment plans align with patient preferences, expectations, and lived experiences.

Emerging therapies and innovations were another focal point, particularly in the context of conditions such as pigmentary disorders, inflammatory diseases, and hair disorders that are more prevalent or uniquely impactful in these populations. While new treatments are expanding the therapeutic landscape, the discussion underscored that clinical trial diversity remains insufficient. Increasing representation of patients with skin of color in research was identified as essential for generating data that are both generalizable and clinically meaningful.

In addition to therapeutic advancements, Nambudiri highlighted the role of community engagement and advocacy in driving change. Efforts to improve outreach, patient education, and trust in the healthcare system were noted as key components in addressing longstanding disparities. The integration of patient voices into both research and clinical practice was also emphasized as a means of ensuring more equitable and effective care delivery.

Overall, the discussion reflected a growing momentum within dermatology to prioritize inclusivity and equity. While meaningful strides have been made, the speakers acknowledged that sustained efforts are needed across education, research, and clinical practice to fully address disparities and improve outcomes for patients with skin of color.

Editor’s note: This summary was developed with the help of AI tools.